Peer-influenced content. Sources you trust. No registration required. This is HCN.

Clinical and Translational Gastroenterology (CTG)Digital Therapeutics: Emerging New Therapy for Nonalcoholic Fatty Liver Disease

Long-term outcomes of lifestyle interventions to promote weight maintenance — the current first-line management for patients with NAFLD — are often unsatisfactory. DTx can overcome the drawbacks of traditional lifestyle treatments through telecare medical services. At the same time, implementing DTx introduces a different level of self-management motivation for patients, greatly improving the treatment adherence and therapeutic effect among NAFLD patients.